Journal for ImmunoTherapy of Cancer (Nov 2021)

506 IGNYTE: an open-label, multicenter, phase 1/2 (Ph 1/2) clinical trial of RP1 ± nivolumab in patients with advanced solid tumors

  • Anna Olsson-Brown,
  • Joseph Sacco,
  • Mark Middleton,
  • Jason Chesney,
  • Mohammed Milhem,
  • Kevin Harrington,
  • Robert Coffin,
  • Katy Tsai,
  • Adel Samson,
  • Bartosz Chmielowski,
  • Ari VanderWalde,
  • Andrea Pirzkall,
  • Jiaxin Niu,
  • Praveen Bommareddy,
  • Georgia Beasley,
  • Gino In,
  • Terence Rhodes,
  • Francesca Aroldi,
  • Lavita Menezes,
  • Tawnya Bowles,
  • Hamid Emamekhoo,
  • Scott Baum,
  • Sophie Dalac-Rat,
  • Katharina Kahler,
  • Eva Muñoz

DOI
https://doi.org/10.1136/jitc-2021-SITC2021.506
Journal volume & issue
Vol. 9, no. Suppl 2

Abstract

Read online

No abstracts available.